AbbVie Inc (ABBV)
203.55
-0.32
(-0.16%)
USD |
NYSE |
Nov 01, 16:00
203.53
-0.02
(-0.01%)
After-Hours: 20:00
AbbVie Price to Book Value: 53.04 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 53.04 |
| October 31, 2024 | 53.13 |
| October 30, 2024 | 52.51 |
| October 29, 2024 | 49.37 |
| October 28, 2024 | 49.43 |
| October 25, 2024 | 48.95 |
| October 24, 2024 | 49.42 |
| October 23, 2024 | 48.96 |
| October 22, 2024 | 49.19 |
| October 21, 2024 | 48.61 |
| October 18, 2024 | 49.22 |
| October 17, 2024 | 49.14 |
| October 16, 2024 | 49.63 |
| October 15, 2024 | 50.00 |
| October 14, 2024 | 50.99 |
| October 11, 2024 | 50.61 |
| October 10, 2024 | 50.65 |
| October 09, 2024 | 50.75 |
| October 08, 2024 | 50.30 |
| October 07, 2024 | 50.45 |
| October 04, 2024 | 50.63 |
| October 03, 2024 | 50.93 |
| October 02, 2024 | 51.29 |
| October 01, 2024 | 51.33 |
| September 30, 2024 | 51.46 |
| Date | Value |
|---|---|
| September 27, 2024 | 50.76 |
| September 26, 2024 | 50.01 |
| September 25, 2024 | 49.84 |
| September 24, 2024 | 50.43 |
| September 23, 2024 | 50.51 |
| September 20, 2024 | 50.42 |
| September 19, 2024 | 50.46 |
| September 18, 2024 | 50.28 |
| September 17, 2024 | 50.41 |
| September 16, 2024 | 51.01 |
| September 13, 2024 | 50.61 |
| September 12, 2024 | 50.56 |
| September 11, 2024 | 50.71 |
| September 10, 2024 | 51.95 |
| September 09, 2024 | 51.19 |
| September 06, 2024 | 50.40 |
| September 05, 2024 | 50.26 |
| September 04, 2024 | 51.34 |
| September 03, 2024 | 51.52 |
| August 30, 2024 | 51.16 |
| August 29, 2024 | 50.86 |
| August 28, 2024 | 50.92 |
| August 27, 2024 | 51.06 |
| August 26, 2024 | 51.45 |
| August 23, 2024 | 51.48 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
9.306
Minimum
Oct 28 2020
53.13
Maximum
Oct 31 2024
20.75
Average
16.82
Median
Price to Book Value Benchmarks
| Amgen Inc | 22.80 |
| Johnson & Johnson | 5.495 |
| Eli Lilly and Co | 54.59 |
| Merck & Co Inc | 5.926 |
| Pfizer Inc | 1.815 |
Price to Book Value Related Metrics
| PE Ratio | 70.68 |
| PS Ratio | 6.499 |
| Price | 203.55 |
| Earnings Yield | 1.41% |
| Market Cap | 359.54B |
| Operating PE Ratio | 24.05 |
| Normalized PE Ratio | 60.85 |